Reverse hierarchical DED assembly in the cFLIP-procaspase-8 and cFLIP-procaspase-8-FADD complexes.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
17 Oct 2024
Historique:
received: 07 06 2024
accepted: 09 10 2024
medline: 18 10 2024
pubmed: 18 10 2024
entrez: 17 10 2024
Statut: epublish

Résumé

cFLIP, a master anti-apoptotic regulator, targets the FADD-induced DED complexes of procaspase-8 in death receptor and ripoptosome signaling pathways. Several tumor cells maintain relatively high levels of cFLIP in achieving their immortality. However, understanding the three-dimensional regulatory mechanism initiated or mediated by elevated levels of cFLIP has been limited by the absence of the atomic coordinates for cFLIP-induced DED complexes. Here we report the crystal plus cryo-EM structures to uncover an unconventional mechanism where cFLIP and procaspase-8 autonomously form a binary tandem DED complex, independent of FADD. This complex gains the ability to recruit FADD, thereby allosterically modulating cFLIP assembly and partially activating caspase-8 for RIPK1 cleavage. Our structure-guided mutagenesis experiments provide critical insights into these regulatory mechanisms, elucidating the resistance to apoptosis and necroptosis in achieving immortality. Finally, this research offers a unified model for the intricate bidirectional hierarchy-based processes using multiprotein helical assembly to govern cell fate decisions.

Identifiants

pubmed: 39419969
doi: 10.1038/s41467-024-53306-1
pii: 10.1038/s41467-024-53306-1
doi:

Substances chimiques

CASP8 and FADD-Like Apoptosis Regulating Protein 0
Caspase 8 EC 3.4.22.-
Fas-Associated Death Domain Protein 0
FADD protein, human 0
Receptor-Interacting Protein Serine-Threonine Kinases EC 2.7.11.1
CASP8 protein, human EC 3.4.22.-
RIPK1 protein, human EC 2.7.11.1
CFLAR protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8974

Subventions

Organisme : Academia Sinica
ID : AS-TP-107-L16
Organisme : Academia Sinica
ID : AS-102-TP-B14-2
Organisme : Academia Sinica
ID : AS-TP-107-L16-1
Organisme : Academia Sinica
ID : AS-102-TP-B14
Organisme : Academia Sinica
ID : AS-TP-107-L16-2
Organisme : Academia Sinica
ID : AS-102-TP-B14-1
Organisme : Academia Sinica
ID : AS-TP-107-L16-3
Organisme : Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan)
ID : 110-2311-B-001-015-
Organisme : Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan)
ID : 109-2311-B-001-016-
Organisme : Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan)
ID : 108-2311-B-001-018-
Organisme : Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan)
ID : 107-2320-B-001-018-
Organisme : Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan)
ID : 107-2320-B-006-062-MY3
Organisme : Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan)
ID : 111-2311-B-006-005-MY3
Organisme : Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan)
ID : 111-2311-B-006-005-MY3

Informations de copyright

© 2024. The Author(s).

Références

Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P. & Kroemer, G. The molecular machinery of regulated cell death. Cell Res 29, 347–364 (2019).
pubmed: 30948788 pmcid: 6796845 doi: 10.1038/s41422-019-0164-5
Singh, R., Letai, A. & Sarosiek, K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat. Rev. Mol. Cell Biol. 20, 175–193 (2019).
pubmed: 30655609 pmcid: 7325303 doi: 10.1038/s41580-018-0089-8
Peter, M. E. et al. The CD95 receptor: apoptosis revisited. Cell 129, 447–450 (2007).
pubmed: 17482535 doi: 10.1016/j.cell.2007.04.031
Wilson, N. S., Dixit, V. & Ashkenazi, A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol. 10, 348–355 (2009).
pubmed: 19295631 doi: 10.1038/ni.1714
Hughes, M. A. et al. Co-operative and hierarchical binding of c-FLIP and caspase-8: a unified model defines how c-FLIP isoforms differentially control cell fate. Mol. Cell 61, 834–849 (2016).
pubmed: 26990987 pmcid: 4819448 doi: 10.1016/j.molcel.2016.02.023
Kischkel, F. C. et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579–5588 (1995).
pubmed: 8521815 pmcid: 394672 doi: 10.1002/j.1460-2075.1995.tb00245.x
Irmler, M. et al. Inhibition of death receptor signals by cellular FLIP. Nature 388, 190–195 (1997).
pubmed: 9217161 doi: 10.1038/40657
Rasper, D. M. et al. Cell death attenuation by ‘Usurpin’, a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ. 5, 271–288 (1998).
pubmed: 10200473 doi: 10.1038/sj.cdd.4400370
Scaffidi, C. et al. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274, 22532–22538 (1999).
pubmed: 10428830 doi: 10.1074/jbc.274.32.22532
Scaffidi, C., Schmitz, I., Krammer, P. H. & Peter, M. E. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274, 1541–1548 (1999).
pubmed: 9880531 doi: 10.1074/jbc.274.3.1541
Peter, M. E. & Krammer, P. H. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10, 26–35 (2003).
pubmed: 12655293 doi: 10.1038/sj.cdd.4401186
Lavrik, I. N. et al. CD95 stimulation results in the formation of a novel death effector domain protein-containing complex. J. Biol. Chem. 283, 26401–26408 (2008).
pubmed: 18635548 pmcid: 3258909 doi: 10.1074/jbc.M800823200
Brenner, D., Blaser, H. & Mak, T. W. Regulation of tumour necrosis factor signalling: live or let die. Nat. Rev. Immunol. 15, 362–374 (2015).
pubmed: 26008591 doi: 10.1038/nri3834
Hsu, H., Huang, J., Shu, H. B., Baichwal, V. & Goeddel, D. V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387–396 (1996).
pubmed: 8612133 doi: 10.1016/S1074-7613(00)80252-6
Shu, H. B., Takeuchi, M. & Goeddel, D. V. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc. Natl Acad. Sci. USA 93, 13973–13978 (1996).
pubmed: 8943045 pmcid: 19479 doi: 10.1073/pnas.93.24.13973
Hsu, H., Xiong, J. & Goeddel, D. V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81, 495–504 (1995).
pubmed: 7758105 doi: 10.1016/0092-8674(95)90070-5
Liu, Z. G., Hsu, H., Goeddel, D. V. & Karin, M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents. Cell death. Cell 87, 565–576 (1996).
pubmed: 8898208
Hsu, H., Shu, H. B., Pan, M. G. & Goeddel, D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299–308 (1996).
pubmed: 8565075 doi: 10.1016/S0092-8674(00)80984-8
Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181–190 (2003).
pubmed: 12887920 doi: 10.1016/S0092-8674(03)00521-X
Varfolomeev, E. E. & Ashkenazi, A. Tumor necrosis factor: an apoptosis JuNKie? Cell 116, 491–497 (2004).
pubmed: 14980217 doi: 10.1016/S0092-8674(04)00166-7
Karin, M. & Lin, A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221–227 (2002).
pubmed: 11875461 doi: 10.1038/ni0302-221
Beg, A. A. & Baltimore, D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274, 782–784 (1996).
pubmed: 8864118 doi: 10.1126/science.274.5288.782
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. & Verma, I. M. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274, 787–789 (1996).
pubmed: 8864120 doi: 10.1126/science.274.5288.787
Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K. & Tschopp, J. NF-kappaB signals induce the expression of c-FLIP. Mol. Cell Biol. 21, 5299–5305 (2001).
pubmed: 11463813 pmcid: 87253 doi: 10.1128/MCB.21.16.5299-5305.2001
Kreuz, S., Siegmund, D., Scheurich, P. & Wajant, H. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell Biol. 21, 3964–3973 (2001).
pubmed: 11359904 pmcid: 87059 doi: 10.1128/MCB.21.12.3964-3973.2001
Harper, N., Hughes, M., MacFarlane, M. & Cohen, G. M. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J. Biol. Chem. 278, 25534–25541 (2003).
pubmed: 12721308 doi: 10.1074/jbc.M303399200
Wang, L., Du, F. & Wang, X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133, 693–703 (2008).
pubmed: 18485876 doi: 10.1016/j.cell.2008.03.036
Safa, A. R. Roles of c-FLIP in Apoptosis, Necroptosis, and Autophagy. J Carcinog Mutagen Suppl 6, https://doi.org/10.4172/2157-2518.S6-003 (2013).
Tsuchiya, Y., Nakabayashi, O. & Nakano, H. FLIP the switch: regulation of apoptosis and necroptosis by cFLIP. Int J. Mol. Sci. 16, 30321–30341 (2015).
pubmed: 26694384 pmcid: 4691174 doi: 10.3390/ijms161226232
Krueger, A., Schmitz, I., Baumann, S., Krammer, P. H. & Kirchhoff, S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 276, 20633–20640 (2001).
pubmed: 11279218 doi: 10.1074/jbc.M101780200
Krueger, A., Baumann, S., Krammer, P. H. & Kirchhoff, S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol. Cell Biol. 21, 8247–8254 (2001).
pubmed: 11713262 pmcid: 99990 doi: 10.1128/MCB.21.24.8247-8254.2001
Oberst, A. et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363–367 (2011).
pubmed: 21368763 pmcid: 3077893 doi: 10.1038/nature09852
Holler, N. et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1, 489–495 (2000).
pubmed: 11101870 doi: 10.1038/82732
Chan, F. K. et al. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J. Biol. Chem. 278, 51613–51621 (2003).
pubmed: 14532286 doi: 10.1074/jbc.M305633200
Yeh, W. C. et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12, 633–642 (2000).
pubmed: 10894163 doi: 10.1016/S1074-7613(00)80214-9
Varfolomeev, E. E. et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267–276 (1998).
pubmed: 9729047 doi: 10.1016/S1074-7613(00)80609-3
Yeh, W. C. et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954–1958 (1998).
pubmed: 9506948 doi: 10.1126/science.279.5358.1954
Li, J. et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150, 339–350 (2012).
pubmed: 22817896 pmcid: 3664196 doi: 10.1016/j.cell.2012.06.019
Dillon, C. P. et al. Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep. 1, 401–407 (2012).
pubmed: 22675671 pmcid: 3366463 doi: 10.1016/j.celrep.2012.03.010
Kaiser, W. J. et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368–372 (2011).
pubmed: 21368762 pmcid: 3060292 doi: 10.1038/nature09857
Dillon, C. P. et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157, 1189–1202 (2014).
pubmed: 24813850 doi: 10.1016/j.cell.2014.04.018
Dannappel, M. et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513, 90–94 (2014).
pubmed: 25132550 doi: 10.1038/nature13608
Gurung, P. et al. FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J. Immunol. 192, 1835–1846 (2014).
pubmed: 24453255 doi: 10.4049/jimmunol.1302839
Humphreys, L., Espona-Fiedler, M. & Longley, D. B. FLIP as a therapeutic target in cancer. Febs J. 285, 4104–4123 (2018).
pubmed: 29806737 doi: 10.1111/febs.14523
Wu, Y. H. et al. Participation of c-FLIP in NLRP3 and AIM2 inflammasome activation. Cell Death Differ. 21, 451–461 (2014).
pubmed: 24270411 doi: 10.1038/cdd.2013.165
Ranjan, K. & Pathak, C. FADD regulates NF-kappaB activation and promotes ubiquitination of cFLIPL to induce apoptosis. Sci. Rep. 6, 22787 (2016).
pubmed: 26972597 doi: 10.1038/srep22787
French, R., Hayward, O., Jones, S., Yang, W. & Clarkson, R. Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL. Mol. Cancer 14, 209 (2015).
pubmed: 26667821 doi: 10.1186/s12943-015-0478-y
Micheau, O. Cellular FLICE-inhibitory protein: an attractive therapeutic target? Expert Opin. Ther. Targets 7, 559–573 (2003).
pubmed: 12885274 doi: 10.1517/14728222.7.4.559
Van Opdenbosch, N. et al. Caspase-1 engagement and TLR-induced c-fLIP expression suppress ASC/Caspase-8-dependent apoptosis by inflammasome sensors NLRP1b and NLRC4. Cell Rep. 21, 3427–3444 (2017).
pubmed: 29262324 doi: 10.1016/j.celrep.2017.11.088
Majkut, J. et al. Differential affinity of FLIP and procaspase 8 for FADD’s DED binding surfaces regulates DISC assembly. Nat. Commun. 5, 3350 (2014).
pubmed: 24577104 doi: 10.1038/ncomms4350
Fu, T. M. et al. Cryo-EM structure of caspase-8 tandem DED filament reveals assembly and regulation mechanisms of the death-inducing signaling complex. Mol. Cell 64, 236–250 (2016).
pubmed: 27746017 pmcid: 5089849 doi: 10.1016/j.molcel.2016.09.009
Schleich, K. et al. Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model. Mol. Cell 47, 306–319 (2012).
pubmed: 22683265 doi: 10.1016/j.molcel.2012.05.006
Dickens, L. S. et al. A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death. Mol. Cell 47, 291–305 (2012).
pubmed: 22683266 pmcid: 3477315 doi: 10.1016/j.molcel.2012.05.004
Humphreys, L. M. et al. A revised model of TRAIL-R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosis. EMBO Rep. 21, e49254 (2020).
pubmed: 32009295 pmcid: 7054686 doi: 10.15252/embr.201949254
Fox, J. L. et al. Cryo-EM structural analysis of FADD:Caspase-8 complexes defines the catalytic dimer architecture for co-ordinated control of cell fate. Nat. Commun. 12, 819 (2021).
pubmed: 33547302 pmcid: 7864959 doi: 10.1038/s41467-020-20806-9
Yang, C. Y. et al. Deciphering DED assembly mechanisms in FADD-procaspase-8-cFLIP complexes regulating apoptosis. Nat. Commun. 15, 3791 (2024).
pubmed: 38710704 pmcid: 11074299 doi: 10.1038/s41467-024-47990-2
Esposito, D. et al. Solution NMR investigation of the CD95/FADD homotypic death domain complex suggests lack of engagement of the CD95 C terminus. Structure 18, 1378–1390 (2010).
pubmed: 20947025 doi: 10.1016/j.str.2010.08.006
Nematollahi, L. A. et al. Flexible stoichiometry and asymmetry of the PIDDosome core complex by heteronuclear NMR spectroscopy and mass spectrometry. J. Mol. Biol. 427, 737–752 (2015).
pubmed: 25528640 pmcid: 4332690 doi: 10.1016/j.jmb.2014.11.021
Su, T. W. et al. Structural insights into DD-fold assembly and caspase-9 activation by the Apaf-1 apoptosome. Structure 25, 407–420 (2017).
pubmed: 28111022 doi: 10.1016/j.str.2016.12.019
Lin, S. C., Lo, Y. C. & Wu, H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465, 885–890 (2010).
pubmed: 20485341 pmcid: 2888693 doi: 10.1038/nature09121
Eberstadt, M. et al. NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Nature 392, 941–945 (1998).
pubmed: 9582077 doi: 10.1038/31972
Kaufmann, M. et al. Identification of a basic surface area of the FADD death effector domain critical for apoptotic signaling. FEBS Lett. 527, 250–254 (2002).
pubmed: 12220669 doi: 10.1016/S0014-5793(02)03146-0
Carrington, P. E. et al. The structure of FADD and its mode of interaction with procaspase-8. Mol. Cell 22, 599–610 (2006).
pubmed: 16762833 doi: 10.1016/j.molcel.2006.04.018
Tsai, M. D., Wu, W. J. & Ho, M. C. Enzymology and dynamics by cryogenic electron microscopy. Annu Rev. Biophys. 51, 19–38 (2022).
pubmed: 34932913 doi: 10.1146/annurev-biophys-100121-075228
Yu, J. W., Jeffrey, P. D. & Shi, Y. Mechanism of procaspase-8 activation by c-FLIPL. Proc. Natl Acad. Sci. USA 106, 8169–8174 (2009).
pubmed: 19416807 pmcid: 2688887 doi: 10.1073/pnas.0812453106
Pop, C. et al. FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem J. 433, 447–457 (2011).
pubmed: 21235526 doi: 10.1042/BJ20101738
Boatright, K. M., Deis, C., Denault, J. B., Sutherlin, D. P. & Salvesen, G. S. Activation of caspases-8 and -10 by FLIP(L). Biochem J. 382, 651–657 (2004).
pubmed: 15209560 pmcid: 1133822 doi: 10.1042/BJ20040809
Hochheiser, I. V. et al. Directionality of PYD filament growth determined by the transition of NLRP3 nucleation seeds to ASC elongation. Sci. Adv. 8, eabn7583 (2022).
pubmed: 35559676 pmcid: 9106292 doi: 10.1126/sciadv.abn7583
Lu, A. et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 156, 1193–1206 (2014).
pubmed: 24630722 pmcid: 4000066 doi: 10.1016/j.cell.2014.02.008
Li, Y. et al. Cryo-EM structures of ASC and NLRC4 CARD filaments reveal a unified mechanism of nucleation and activation of caspase-1. Proc. Natl Acad. Sci. USA 115, 10845–10852 (2018).
pubmed: 30279182 pmcid: 6205419 doi: 10.1073/pnas.1810524115
Shen, C. et al. Molecular mechanism for NLRP6 inflammasome assembly and activation. Proc. Natl Acad. Sci. USA 116, 2052–2057 (2019).
pubmed: 30674671 pmcid: 6369754 doi: 10.1073/pnas.1817221116
Schlauderer, F. et al. Molecular architecture and regulation of BCL10-MALT1 filaments. Nat. Commun. 9, 4041 (2018).
pubmed: 30279415 pmcid: 6168461 doi: 10.1038/s41467-018-06573-8
Safa, A. R., Kamocki, K., Saadatzadeh, M. R. & Bijangi-Vishehsaraei, K. c-FLIP, a Novel biomarker for cancer prognosis, immunosuppression, alzheimer’s disease, chronic obstructive pulmonary disease (copd), and a rationale therapeutic target. Biomark J. 5, https://doi.org/10.36648/2472-1646.5.1.59 (2019).
Lee, J. S. et al. FLIP-mediated autophagy regulation in cell death control. Nat. Cell Biol. 11, 1355–1362 (2009).
pubmed: 19838173 pmcid: 2802862 doi: 10.1038/ncb1980
Lo, Y. C., Lin, S. C., Yang, C. Y. & Tung, J. Y. Tandem DEDs and CARDs suggest novel mechanisms of signaling complex assembly. Apoptosis 20, 124–135 (2015).
pubmed: 25398537 doi: 10.1007/s10495-014-1054-4
Wu, H. Higher-order assemblies in a new paradigm of signal transduction. Cell 153, 287–292 (2013).
pubmed: 23582320 pmcid: 3687143 doi: 10.1016/j.cell.2013.03.013
Konig, C. et al. Targeting type I DED interactions at the DED filament serves as a sensitive switch for cell fate decisions. Cell Chem. Biol. https://doi.org/10.1016/j.chembiol.2024.06.014 (2024).
Yaacoub, K. et al. The identification of new c-flip inhibitors for restoring apoptosis in trail-resistant cancer cells. Curr. Issues Mol. Biol. 46, 710–728 (2024).
pubmed: 38248348 pmcid: 10814526 doi: 10.3390/cimb46010046
Laussmann, M. A. et al. Proteasome inhibition can impair caspase-8 activation upon submaximal stimulation of apoptotic tumor necrosis factor-related apoptosis inducing ligand (TRAIL) signaling. J. Biol. Chem. 287, 14402–14411 (2012).
pubmed: 22408249 pmcid: 3340270 doi: 10.1074/jbc.M111.304378

Auteurs

Chao-Yu Yang (CY)

Genomics Research Center, Academia Sinica, Taipei, 11529, Taiwan.

Yi-Chun Tseng (YC)

Genomics Research Center, Academia Sinica, Taipei, 11529, Taiwan.
Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, 70101, Taiwan.

Yi-Fan Tu (YF)

Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, 70101, Taiwan.

Bai-Jiun Kuo (BJ)

Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, 70101, Taiwan.

Li-Chung Hsu (LC)

Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, 10002, Taiwan.
Center of Precision Medicine, College of Medicine, National Taiwan University, Taipei, 10002, Taiwan.

Chia-I Lien (CI)

Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, 10002, Taiwan.

You-Sheng Lin (YS)

Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, 10002, Taiwan.

Yin-Ting Wang (YT)

Genomics Research Center, Academia Sinica, Taipei, 11529, Taiwan.

Yen-Chen Lu (YC)

Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, 70101, Taiwan.

Tsung-Wei Su (TW)

Genomics Research Center, Academia Sinica, Taipei, 11529, Taiwan.

Yu-Chih Lo (YC)

Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, 70101, Taiwan. gracelo@ncku.edu.tw.

Su-Chang Lin (SC)

Genomics Research Center, Academia Sinica, Taipei, 11529, Taiwan. tomlin@gate.sinica.edu.tw.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH